Abstract
The purpose of this qualitative study is to understand changing illicit drug use patterns in rural Appalachia since a new formulation of OxyContin® was released with the goal of deterring diversion and misuse. Participants (n = 25) from a longitudinal study of rural drug users (N = 192) were approached to participate in semistructured qualitative interviews between April and June 2011. The primary finding is that the majority of participants switched from using the original formulation OxyContin to immediate-release oxycodone. We discuss the implications and limitations of these findings.
| Original language | English |
|---|---|
| Pages (from-to) | 770-774 |
| Number of pages | 5 |
| Journal | Substance Use and Misuse |
| Volume | 49 |
| Issue number | 6 |
| DOIs | |
| State | Published - May 2014 |
Bibliographical note
Funding Information:This study was funded by Purdue Pharma LP, Inc. The authors alone are responsible for the content and writing of the article.
Funding
This study was funded by Purdue Pharma LP, Inc. The authors alone are responsible for the content and writing of the article.
| Funders |
|---|
| Purdue Pharma L.P. |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Misuse deterrence
- OxyContin®
- Prescription drug
- Rural
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Health(social science)
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Does the new formulation of oxycontin® deter misuse? A qualitative analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver